A House committee subpoenaed former drug CEO Martin Shkreli to attend a hearing on drug prices and testify on his former firm's decision to increase a critical drug's price by over 5,000 percent. Whether Shkreli will appear remains to be seen.
A House committee subpoenaed former drug CEO Martin Shkreli to attend a hearing on drug prices and testify on his former firm's decision to increase a critical drug's price by over 5,000 percent. Whether Shkreli will appear remains to be seen.
Share this Article
Recommended